"Moleculent Secures $26M Series A Funding to Expand Operations and Advance Research Platform"
Moleculent Raises $26M in Series A Financing
(Linkedin), a biotechnology research company based in Sweden, has secured $26M in Series A funding. This investment will fuel their expansion efforts and further their research and development in functional biology, offering advanced tools and insights to accelerate drug discovery and development processes.
Funding Amount: $26 million
Industry: Biotechnology Research
Employee Count: 11-50
CEO: Olle Ericsson (CEO Linkedin)
What Moleculent needs to buy: Moleculent is seeking collaborations with research institutions, biotech companies, and scientific experts in functional biology. These partnerships will help them enhance their functional profiling platform, expand their market reach, and validate their innovative solutions in the field of cellular-level research and drug discovery.